Syndax Pharmaceuticals Inc. (SNDX) NASDAQ

$26.53 -1.43 (-5.11%)

Market Cap: $1.68B

As of 02/06/23 04:00 PM EST. Market closed.

(SNDX)

Syndax Pharmaceuticals Inc. (SNDX) NASDAQ

$26.53 -1.43 (-5.11%)

Market Cap: $1.68B

As of 02/06/23 04:00 PM EST. Market closed.

Syndax Pharmaceuticals is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. The Company's pipeline includes SNDX-5613, a highly selective inhibitor of the Menin-MLL binding interaction, axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor, and entinostat, a class I HDAC ... read more

Syndax Pharmaceuticals is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. The Company's pipeline includes SNDX-5613, a highly selective inhibitor of the Menin-MLL binding interaction, axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor, and entinostat, a class I HDAC inhibitor. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Briggs Morrison
Full Time Employees
59
CEO Compensation (Base)
$566,073
CEO Compensation (Total)
$2.08M
URL
Address
Building D, 35 Gatehouse Dr Fl 3, Massachusetts, Waltham, 02451-1215.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Briggs Morrison
Full Time Employees
59
CEO Compensation (Base)
$566,073
CEO Compensation (Total)
$2.08M
Address
Building D, 35 Gatehouse Dr Fl 3, Massachusetts, Waltham, 02451-1215.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$27.87
Previous Close
$27.96
Days Range
$26.49 - $27.91
52 week range
$13.27 - $29.86
Volume
726,565
Avg. Volume (30 days)
727,880
Market Cap
$1.68B
Dividend Yield
0.00%
P/E
-120.74
Shares Outstanding
60,223,498
Open
$27.87
Previous Close
$27.96
Days Range
$26.49 - $27.91
52 week range
$13.27 - $29.86
Volume
726,565
Avg. Volume (30 days)
727,880
Market Cap
$1.68B
Dividend Yield
0.00%
P/E
-120.74
Shares Outstanding
60,223,498

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SYNDAX PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Ordentlich PeterChief Scientific OfficerJan 31, 2023 Option Exercise$17.32691,19569Feb 03, 2023, 04:59 PM
Ordentlich PeterChief Scientific OfficerFeb 01, 2023 Sale$28.43691,9620Feb 03, 2023, 04:59 PM
Legault PierreDirectorJan 13, 2023 Option Exercise$13.5815,000203,70042,000Jan 13, 2023, 04:44 PM
Legault PierreDirectorJan 12, 2023 Option Exercise$9.4724,000227,28056,000Jan 13, 2023, 04:44 PM
Legault PierreDirectorJan 13, 2023 Sale$27.0015,000405,00032,000Jan 13, 2023, 04:44 PM
Legault PierreDirectorJan 12, 2023 Sale$26.7424,000641,78232,000Jan 13, 2023, 04:44 PM
Ordentlich PeterChief Scientific OfficerDec 02, 2022 Option Exercise$6.3817,200109,73617,465Dec 02, 2022, 05:01 PM
Ordentlich PeterChief Scientific OfficerDec 01, 2022 Option Exercise$6.377,80049,6514,293Dec 02, 2022, 05:01 PM
Ordentlich PeterChief Scientific OfficerDec 02, 2022 Sale$25.0517,200430,936265Dec 02, 2022, 05:01 PM
Ordentlich PeterChief Scientific OfficerDec 01, 2022 Sale$25.017,800195,089265Dec 02, 2022, 05:01 PM
Katkin KeithDirectorOct 06, 2022 Option Exercise$8.2029,899245,17752,782Oct 07, 2022, 04:05 PM
Katkin KeithDirectorOct 06, 2022 Sale$25.9029,899774,41132,000Oct 07, 2022, 04:05 PM
Metzger Michael AChief Executive OfficerOct 06, 2022 Option Exercise$8.7716,231142,34633,890Oct 07, 2022, 04:05 PM
Metzger Michael AChief Executive OfficerOct 06, 2022 Sale$25.2916,231410,50817,659Oct 07, 2022, 04:05 PM
Metzger Michael AChief Executive OfficerOct 04, 2022 Option Exercise$8.771,28011,22618,939Oct 04, 2022, 05:49 PM
Metzger Michael AChief Executive OfficerOct 03, 2022 Option Exercise$8.772,88325,28420,542Oct 04, 2022, 05:49 PM
Metzger Michael AChief Executive OfficerSep 30, 2022 Option Exercise$8.7729,606259,64547,265Oct 04, 2022, 05:49 PM
Metzger Michael AChief Executive OfficerOct 04, 2022 Sale$25.021,28032,02617,659Oct 04, 2022, 05:49 PM
Metzger Michael AChief Executive OfficerOct 03, 2022 Sale$25.012,88372,10717,659Oct 04, 2022, 05:49 PM
Metzger Michael AChief Executive OfficerSep 30, 2022 Sale$25.0229,606740,75717,659Oct 04, 2022, 05:49 PM
Katkin KeithDirectorOct 04, 2022 Option Exercise$8.533603,07132,223Oct 04, 2022, 05:49 PM
Katkin KeithDirectorOct 03, 2022 Option Exercise$7.961801,43232,167Oct 04, 2022, 05:49 PM
Katkin KeithDirectorSep 30, 2022 Option Exercise$8.073,56128,74034,914Oct 04, 2022, 05:49 PM
Katkin KeithDirectorOct 04, 2022 Sale$25.003609,00032,000Oct 04, 2022, 05:49 PM
Katkin KeithDirectorOct 03, 2022 Sale$25.001804,50032,000Oct 04, 2022, 05:49 PM
Katkin KeithDirectorSep 30, 2022 Sale$25.073,56189,27732,000Oct 04, 2022, 05:49 PM
Morrison BriggsPresident, Head of R&DSep 20, 2022 Option Exercise$10.9059,649650,17477,485Sep 21, 2022, 04:18 PM
Morrison BriggsPresident, Head of R&DSep 19, 2022 Option Exercise$10.90114,3391,246,295132,175Sep 21, 2022, 04:18 PM
Morrison BriggsPresident, Head of R&DSep 20, 2022 Sale$23.2559,6491,387,01217,836Sep 21, 2022, 04:18 PM
Morrison BriggsPresident, Head of R&DSep 19, 2022 Sale$23.03114,3392,633,04417,836Sep 21, 2022, 04:18 PM
Morrison BriggsPresident, Head of R&DSep 14, 2022 Option Exercise$7.2087,645631,044105,481Sep 16, 2022, 05:34 PM
Morrison BriggsPresident, Head of R&DSep 16, 2022 Option Exercise$8.77125,0001,096,22689,802Sep 16, 2022, 05:34 PM
Morrison BriggsPresident, Head of R&DSep 15, 2022 Option Exercise$7.2066,775480,78084,611Sep 16, 2022, 05:34 PM
Morrison BriggsPresident, Head of R&DSep 16, 2022 Sale$23.22125,0002,902,43717,836Sep 16, 2022, 05:34 PM
Morrison BriggsPresident, Head of R&DSep 15, 2022 Sale$24.2066,7751,616,03517,836Sep 16, 2022, 05:34 PM
Morrison BriggsPresident, Head of R&DSep 14, 2022 Sale$23.8087,6452,085,85517,836Sep 16, 2022, 05:34 PM
Podlesak DennisDirectorSep 15, 2022 Option Exercise$6.3266,840422,429142,603Sep 16, 2022, 05:34 PM
Podlesak DennisDirectorSep 16, 2022 Option Exercise$6.3411,97575,87982,319Sep 16, 2022, 05:34 PM
Podlesak DennisDirectorSep 15, 2022 Sale$24.2066,8401,617,38175,763Sep 16, 2022, 05:34 PM
Podlesak DennisDirectorSep 16, 2022 Sale$23.4311,975280,60775,763Sep 16, 2022, 05:34 PM
Ordentlich PeterChief Scientific OfficerJul 29, 2022 Option Exercise$14.122653,742265Aug 26, 2022, 04:14 PM
Ordentlich PeterChief Scientific OfficerAug 24, 2022 Option Exercise$6.3225,000158,06523,111Aug 26, 2022, 04:14 PM
Ordentlich PeterChief Scientific OfficerAug 24, 2022 Sale$25.0425,000625,892265Aug 26, 2022, 04:14 PM
Legault PierreDirectorAug 05, 2022 Option Exercise$9.2224,000221,32046,000Aug 09, 2022, 04:05 PM
Legault PierreDirectorAug 05, 2022 Sale$23.0224,000552,38232,000Aug 09, 2022, 04:05 PM
Metzger Michael AChief Executive OfficerJul 25, 2022 Option Exercise$6.3831,602201,62137,423Jul 27, 2022, 06:42 PM
Metzger Michael AChief Executive OfficerJul 25, 2022 Sale$21.0631,602665,39317,659Jul 27, 2022, 06:42 PM
Metzger Michael AChief Executive OfficerJul 07, 2022 Option Exercise$6.3810063817,759Jul 08, 2022, 05:51 PM
Metzger Michael AChief Executive OfficerJul 06, 2022 Option Exercise$6.3815,00995,75732,668Jul 08, 2022, 05:51 PM
Metzger Michael AChief Executive OfficerJul 07, 2022 Sale$21.001002,10017,659Jul 08, 2022, 05:51 PM
Metzger Michael AChief Executive OfficerJul 06, 2022 Sale$21.0715,009316,30717,659Jul 08, 2022, 05:51 PM
Morrison BriggsPresident, Head of R&DApr 01, 2022 Option Exercise$7.2070,545507,92488,381Apr 13, 2022, 04:09 PM
Morrison BriggsPresident, Head of R&DApr 04, 2022 Option Exercise$7.203,12822,52220,964Apr 13, 2022, 04:09 PM
Morrison BriggsPresident, Head of R&DApr 04, 2022 Option Exercise$10.903,12834,09520,964Apr 05, 2022, 04:05 PM
Morrison BriggsPresident, Head of R&DApr 01, 2022 Option Exercise$10.9070,545768,94088,381Apr 05, 2022, 04:05 PM
Morrison BriggsPresident, Head of R&DApr 04, 2022 Sale$18.293,12857,22017,836Apr 05, 2022, 04:05 PM
Morrison BriggsPresident, Head of R&DApr 01, 2022 Sale$17.45101,0451,763,51542,336Apr 05, 2022, 04:05 PM
Ordentlich PeterChief Scientific OfficerJan 31, 2022 Option Exercise$12.391,41217,4951,412Feb 03, 2022, 05:32 PM
Ordentlich PeterChief Scientific OfficerFeb 01, 2022 Sale$16.651,41223,5100Feb 03, 2022, 05:32 PM
Meyers Michael L.SVP, Chief Medical OfficerJan 31, 2022 Option Exercise$12.391,71421,23623,280Feb 03, 2022, 05:31 PM
Nolte AlexanderChief Accounting OfficerJan 31, 2022 Option Exercise$12.3996811,994968Feb 03, 2022, 05:31 PM
Nolte AlexanderChief Accounting OfficerFeb 01, 2022 Sale$16.6596816,1170Feb 03, 2022, 05:31 PM
Meyers Michael L.SVP, Chief Medical OfficerDec 30, 2021 Option Exercise$8.775,90051,74321,566Jan 03, 2022, 04:03 PM
Legault PierreDirectorDec 22, 2021 Option Exercise$7.8824,000189,12040,000Dec 22, 2021, 06:25 PM
Legault PierreDirectorDec 20, 2021 Option Exercise$7.0820,000141,60036,000Dec 22, 2021, 06:25 PM
Legault PierreDirectorDec 20, 2021 Sale$21.0120,000420,25016,000Dec 22, 2021, 06:25 PM
Legault PierreDirectorDec 22, 2021 Sale$22.0124,000528,20616,000Dec 22, 2021, 06:25 PM
Morrison BriggsChief Executive OfficerDec 17, 2021 Option Exercise$10.9035,156383,20083,492Dec 20, 2021, 06:44 PM
Morrison BriggsChief Executive OfficerDec 17, 2021 Sale$20.0035,156703,12048,336Dec 20, 2021, 06:44 PM
Metzger Michael APresident and COODec 16, 2021 Option Exercise$6.3822,715144,92240,374Dec 20, 2021, 06:44 PM
Metzger Michael APresident and COODec 20, 2021 Option Exercise$8.1461,000496,73062,659Dec 20, 2021, 06:44 PM
Metzger Michael APresident and COODec 17, 2021 Option Exercise$6.381,67610,69319,335Dec 20, 2021, 06:44 PM
Metzger Michael APresident and COODec 16, 2021 Sale$19.0822,715433,40017,659Dec 20, 2021, 06:44 PM
Metzger Michael APresident and COODec 20, 2021 Sale$20.2961,0001,237,56817,659Dec 20, 2021, 06:44 PM
Metzger Michael APresident and COODec 17, 2021 Sale$19.021,67631,87717,659Dec 20, 2021, 06:44 PM
Metzger Michael APresident and COODec 13, 2021 Option Exercise$6.4336,609235,24252,223Dec 15, 2021, 05:35 PM
Metzger Michael APresident and COODec 13, 2021 Sale$19.0536,609697,51917,659Dec 15, 2021, 05:35 PM
Egros FabriceDirectorNov 18, 2021 Option Exercise$8.9314,030125,25630,000Nov 19, 2021, 04:06 PM
Egros FabriceDirectorNov 18, 2021 Sale$18.0314,030252,99316,000Nov 19, 2021, 04:06 PM
Metzger Michael APresident and COOOct 26, 2021 Option Exercise$7.2016,296117,33133,955Oct 27, 2021, 04:11 PM
Metzger Michael APresident and COOOct 25, 2021 Option Exercise$7.2044,704321,86962,363Oct 27, 2021, 04:11 PM
Metzger Michael APresident and COOOct 26, 2021 Sale$19.2016,296312,82517,659Oct 27, 2021, 04:11 PM
Metzger Michael APresident and COOOct 25, 2021 Sale$19.1344,704855,33517,659Oct 27, 2021, 04:11 PM
Metzger Michael APresident and COOSep 27, 2021 Option Exercise$7.2024,437175,94642,096Sep 28, 2021, 04:36 PM
Metzger Michael APresident and COOSep 27, 2021 Sale$19.5124,437476,83217,659Sep 28, 2021, 04:36 PM
Metzger Michael APresident and COOSep 22, 2021 Option Exercise$7.203002,16017,959Sep 22, 2021, 04:50 PM
Metzger Michael APresident and COOSep 21, 2021 Option Exercise$7.204,80834,61822,467Sep 22, 2021, 04:50 PM
Metzger Michael APresident and COOSep 20, 2021 Option Exercise$7.2031,455226,47649,114Sep 22, 2021, 04:50 PM
Metzger Michael APresident and COOSep 22, 2021 Sale$19.023005,70617,659Sep 22, 2021, 04:50 PM
Metzger Michael APresident and COOSep 21, 2021 Sale$19.164,80892,10817,659Sep 22, 2021, 04:50 PM
Metzger Michael APresident and COOSep 20, 2021 Sale$19.2431,455605,04617,659Sep 22, 2021, 04:50 PM
Morrison BriggsChief Executive OfficerSep 20, 2021 Option Exercise$7.205036048,386Sep 21, 2021, 04:35 PM
Morrison BriggsChief Executive OfficerSep 17, 2021 Option Exercise$7.2070,262505,886118,598Sep 21, 2021, 04:35 PM
Morrison BriggsChief Executive OfficerSep 20, 2021 Sale$20.00501,00048,336Sep 21, 2021, 04:35 PM
Morrison BriggsChief Executive OfficerSep 17, 2021 Sale$20.0770,2621,410,01848,336Sep 21, 2021, 04:35 PM
Metzger Michael APresident and COOSep 13, 2021 Option Exercise$7.2016,651119,88734,310Sep 15, 2021, 04:16 PM
Metzger Michael APresident and COOSep 14, 2021 Option Exercise$7.2044,349319,31362,008Sep 15, 2021, 04:16 PM
Metzger Michael APresident and COOSep 13, 2021 Sale$19.0216,651316,63917,659Sep 15, 2021, 04:16 PM
Metzger Michael APresident and COOSep 14, 2021 Sale$19.1544,349849,39417,659Sep 15, 2021, 04:16 PM
Egros FabriceDirectorAug 18, 2021 Option Exercise$7.8815,635123,20431,635Aug 20, 2021, 04:32 PM
Egros FabriceDirectorAug 18, 2021 Sale$15.7515,635246,32816,000Aug 20, 2021, 04:32 PM
Egros FabriceDirectorMay 18, 2021 Option Exercise$7.2813,60999,12929,609May 20, 2021, 04:46 PM
Egros FabriceDirectorMay 18, 2021 Sale$18.6513,609253,78317,683May 20, 2021, 04:46 PM
Meyers Michael L.SVP, Chief Medical OfficerApr 26, 2021 Buy$15.465007,73015,666Apr 28, 2021, 04:15 PM
Podlesak DennisDirectorApr 22, 2021 Buy$14.1113,967197,07743,300Apr 22, 2021, 05:06 PM
Egros FabriceDirectorMar 01, 2021 Option Exercise$6.3610,24165,09326,241Mar 03, 2021, 04:16 PM
Egros FabriceDirectorMar 01, 2021 Sale$24.3110,241248,98116,074Mar 03, 2021, 04:16 PM
Morrison BriggsChief Executive OfficerFeb 08, 2021 Option Exercise$7.2035,156253,12383,492Feb 10, 2021, 04:23 PM
Morrison BriggsChief Executive OfficerFeb 08, 2021 Sale$20.5535,156722,40348,336Feb 10, 2021, 04:23 PM
Morrison BriggsChief Executive OfficerJan 31, 2021 Option Exercise$12.001,77121,25248,336Feb 05, 2021, 04:21 PM
Meyers Michael L.SVP, Chief Medical OfficerJan 31, 2021 Option Exercise$12.001,77121,25215,166Feb 05, 2021, 04:21 PM
Meyers Michael L.SVP, Chief Medical OfficerJul 31, 2020 Option Exercise$7.972,66521,24013,395Feb 05, 2021, 04:21 PM
Metzger Michael APresident and COOFeb 01, 2021 Option Exercise$7.2015,000108,00032,659Feb 03, 2021, 05:53 PM
Metzger Michael APresident and COOFeb 01, 2021 Sale$20.1915,000302,79917,659Feb 03, 2021, 05:53 PM
Metzger Michael APresident and COODec 01, 2020 Option Exercise$7.2015,000108,00032,659Dec 03, 2020, 06:05 PM
Metzger Michael APresident and COODec 01, 2020 Sale$22.9715,000344,51317,659Dec 03, 2020, 06:05 PM
Ordentlich PeterChief Scientific OfficerNov 23, 2020 Option Exercise$3.0829,97292,31429,972Nov 25, 2020, 04:38 PM
Ordentlich PeterChief Scientific OfficerNov 23, 2020 Sale$23.1629,972694,12124,288Nov 25, 2020, 04:38 PM
Morrison BriggsChief Executive OfficerNov 10, 2020 Option Exercise$7.2017,466125,75564,031Nov 12, 2020, 05:55 PM
Morrison BriggsChief Executive OfficerNov 09, 2020 Option Exercise$7.2062,938453,154109,503Nov 12, 2020, 05:55 PM
Morrison BriggsChief Executive OfficerNov 10, 2020 Sale$20.0617,466350,31246,565Nov 12, 2020, 05:55 PM
Morrison BriggsChief Executive OfficerNov 09, 2020 Sale$20.0462,9381,261,26546,565Nov 12, 2020, 05:55 PM
Metzger Michael APresident and COONov 04, 2020 Option Exercise$7.20100,000720,000117,659Nov 06, 2020, 05:55 PM
Metzger Michael APresident and COONov 04, 2020 Sale$20.31100,0002,031,41017,659Nov 06, 2020, 05:55 PM
Shea Richard PChief Financial OfficerJan 31, 2020 Option Exercise$7.971,50511,9957,121Feb 14, 2020, 04:37 PM
Shea Richard PChief Financial OfficerJul 31, 2019 Option Exercise$4.891,4016,8515,616Feb 14, 2020, 04:37 PM
Morrison BriggsChief Executive OfficerFeb 04, 2020 Buy$8.0012,500100,00043,900Feb 05, 2020, 04:07 PM
Morrison BriggsChief Executive OfficerOct 10, 2019 Buy$5.4011,00059,40031,400Oct 11, 2019, 06:33 AM
Morrison BriggsChief Executive OfficerMay 09, 2019 Buy$7.5513,20099,72613,200May 13, 2019, 04:11 PM
Morrison BriggsChief Executive OfficerMay 13, 2019 Buy$7.297,20052,51720,400May 13, 2019, 04:11 PM
Meyers Michael L.SVP, Chief Medical OfficerMar 21, 2019 Buy$4.878397,230Mar 25, 2019, 04:03 PM
Meyers Michael L.SVP, Chief Medical OfficerMar 21, 2019 Buy$4.921,1045,4367,222Mar 22, 2019, 04:05 PM
Shea Richard PChief Financial OfficerJan 31, 2019 Option Exercise$4.762,52112,0004,215Feb 08, 2019, 04:27 PM
Meyers Michael L.SVP, Chief Medical OfficerJan 31, 2019 Option Exercise$4.763,72017,7076,118Feb 08, 2019, 04:27 PM
Metzger Michael APresident and COOJan 31, 2019 Option Exercise$4.762,65912,6572,659Feb 08, 2019, 04:27 PM
Meyers Michael L.SVP, Chief Medical OfficerOct 30, 2018 Buy$4.792009582,398Nov 07, 2018, 04:02 PM
Ordentlich PeterChief Scientific OfficerApr 03, 2018 Option Exercise$3.087,50023,1007,500Apr 03, 2018, 04:42 PM
Ordentlich PeterChief Scientific OfficerApr 03, 2018 Sale$15.007,500112,5000Apr 03, 2018, 04:42 PM
Ordentlich PeterChief Scientific OfficerMay 17, 2017 Option Exercise$3.087322,2555,000May 19, 2017, 11:27 AM
Ordentlich PeterChief Scientific OfficerMay 17, 2017 Sale$15.005,00075,0000May 19, 2017, 11:27 AM
ROYSTON IVORDirectorMar 20, 2017 Option Exercise$13.75125,0001,718,750625,545Mar 22, 2017, 01:37 PM
ROYSTON IVORDirectorMar 08, 2016 Buy$12.00150,0001,800,000750,545Mar 08, 2016, 06:38 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Ordentlich PeterChief Scientific Officer01/31/20231,195
Ordentlich PeterChief Scientific Officer02/01/20231,962
Legault PierreDirector01/13/2023203,700
Legault PierreDirector01/12/2023227,280
Legault PierreDirector01/13/2023405,000
Legault PierreDirector01/12/2023641,782
Ordentlich PeterChief Scientific Officer12/02/2022109,736
Ordentlich PeterChief Scientific Officer12/01/202249,651
Ordentlich PeterChief Scientific Officer12/02/2022430,936
Ordentlich PeterChief Scientific Officer12/01/2022195,089
Katkin KeithDirector10/06/2022245,177
Katkin KeithDirector10/06/2022774,411
Metzger Michael AChief Executive Officer10/06/2022142,346
Metzger Michael AChief Executive Officer10/06/2022410,508
Metzger Michael AChief Executive Officer10/04/202211,226
Metzger Michael AChief Executive Officer10/03/202225,284
Metzger Michael AChief Executive Officer09/30/2022259,645
Metzger Michael AChief Executive Officer10/04/202232,026
Metzger Michael AChief Executive Officer10/03/202272,107
Metzger Michael AChief Executive Officer09/30/2022740,757
Katkin KeithDirector10/04/20223,071
Katkin KeithDirector10/03/20221,432
Katkin KeithDirector09/30/202228,740
Katkin KeithDirector10/04/20229,000
Katkin KeithDirector10/03/20224,500
Katkin KeithDirector09/30/202289,277
Morrison BriggsPresident, Head of R&D09/20/2022650,174
Morrison BriggsPresident, Head of R&D09/19/20221,246,295
Morrison BriggsPresident, Head of R&D09/20/20221,387,012
Morrison BriggsPresident, Head of R&D09/19/20222,633,044
Morrison BriggsPresident, Head of R&D09/14/2022631,044
Morrison BriggsPresident, Head of R&D09/16/20221,096,226
Morrison BriggsPresident, Head of R&D09/15/2022480,780
Morrison BriggsPresident, Head of R&D09/16/20222,902,437
Morrison BriggsPresident, Head of R&D09/15/20221,616,035
Morrison BriggsPresident, Head of R&D09/14/20222,085,855
Podlesak DennisDirector09/15/2022422,429
Podlesak DennisDirector09/16/202275,879
Podlesak DennisDirector09/15/20221,617,381
Podlesak DennisDirector09/16/2022280,607
Ordentlich PeterChief Scientific Officer07/29/20223,742
Ordentlich PeterChief Scientific Officer08/24/2022158,065
Ordentlich PeterChief Scientific Officer08/24/2022625,892
Legault PierreDirector08/05/2022221,320
Legault PierreDirector08/05/2022552,382
Metzger Michael AChief Executive Officer07/25/2022201,621
Metzger Michael AChief Executive Officer07/25/2022665,393
Metzger Michael AChief Executive Officer07/07/2022638
Metzger Michael AChief Executive Officer07/06/202295,757
Metzger Michael AChief Executive Officer07/07/20222,100
Metzger Michael AChief Executive Officer07/06/2022316,307
Morrison BriggsPresident, Head of R&D04/01/2022507,924
Morrison BriggsPresident, Head of R&D04/04/202222,522
Morrison BriggsPresident, Head of R&D04/04/202234,095
Morrison BriggsPresident, Head of R&D04/01/2022768,940
Morrison BriggsPresident, Head of R&D04/04/202257,220
Morrison BriggsPresident, Head of R&D04/01/20221,763,515
Ordentlich PeterChief Scientific Officer01/31/202217,495
Ordentlich PeterChief Scientific Officer02/01/202223,510
Meyers Michael L.SVP, Chief Medical Officer01/31/202221,236
Nolte AlexanderChief Accounting Officer01/31/202211,994
Nolte AlexanderChief Accounting Officer02/01/202216,117
Meyers Michael L.SVP, Chief Medical Officer12/30/202151,743
Legault PierreDirector12/22/2021189,120
Legault PierreDirector12/20/2021141,600
Legault PierreDirector12/20/2021420,250
Legault PierreDirector12/22/2021528,206
Morrison BriggsChief Executive Officer12/17/2021383,200
Morrison BriggsChief Executive Officer12/17/2021703,120
Metzger Michael APresident and COO12/16/2021144,922
Metzger Michael APresident and COO12/20/2021496,730
Metzger Michael APresident and COO12/17/202110,693
Metzger Michael APresident and COO12/16/2021433,400
Metzger Michael APresident and COO12/20/20211,237,568
Metzger Michael APresident and COO12/17/202131,877
Metzger Michael APresident and COO12/13/2021235,242
Metzger Michael APresident and COO12/13/2021697,519
Egros FabriceDirector11/18/2021125,256
Egros FabriceDirector11/18/2021252,993
Metzger Michael APresident and COO10/26/2021117,331
Metzger Michael APresident and COO10/25/2021321,869
Metzger Michael APresident and COO10/26/2021312,825
Metzger Michael APresident and COO10/25/2021855,335
Metzger Michael APresident and COO09/27/2021175,946
Metzger Michael APresident and COO09/27/2021476,832
Metzger Michael APresident and COO09/22/20212,160
Metzger Michael APresident and COO09/21/202134,618
Metzger Michael APresident and COO09/20/2021226,476
Metzger Michael APresident and COO09/22/20215,706
Metzger Michael APresident and COO09/21/202192,108
Metzger Michael APresident and COO09/20/2021605,046
Morrison BriggsChief Executive Officer09/20/2021360
Morrison BriggsChief Executive Officer09/17/2021505,886
Morrison BriggsChief Executive Officer09/20/20211,000
Morrison BriggsChief Executive Officer09/17/20211,410,018
Metzger Michael APresident and COO09/13/2021119,887
Metzger Michael APresident and COO09/14/2021319,313
Metzger Michael APresident and COO09/13/2021316,639
Metzger Michael APresident and COO09/14/2021849,394
Egros FabriceDirector08/18/2021123,204
Egros FabriceDirector08/18/2021246,328
Egros FabriceDirector05/18/202199,129
Egros FabriceDirector05/18/2021253,783
Meyers Michael L.SVP, Chief Medical Officer04/26/20217,730
Podlesak DennisDirector04/22/2021197,077
Egros FabriceDirector03/01/202165,093
Egros FabriceDirector03/01/2021248,981
Morrison BriggsChief Executive Officer02/08/2021253,123
Morrison BriggsChief Executive Officer02/08/2021722,403
Morrison BriggsChief Executive Officer01/31/202121,252
Meyers Michael L.SVP, Chief Medical Officer01/31/202121,252
Meyers Michael L.SVP, Chief Medical Officer07/31/202021,240
Metzger Michael APresident and COO02/01/2021108,000
Metzger Michael APresident and COO02/01/2021302,799
Metzger Michael APresident and COO12/01/2020108,000
Metzger Michael APresident and COO12/01/2020344,513
Ordentlich PeterChief Scientific Officer11/23/202092,314
Ordentlich PeterChief Scientific Officer11/23/2020694,121
Morrison BriggsChief Executive Officer11/10/2020125,755
Morrison BriggsChief Executive Officer11/09/2020453,154
Morrison BriggsChief Executive Officer11/10/2020350,312
Morrison BriggsChief Executive Officer11/09/20201,261,265
Metzger Michael APresident and COO11/04/2020720,000
Metzger Michael APresident and COO11/04/20202,031,410
Shea Richard PChief Financial Officer01/31/202011,995
Shea Richard PChief Financial Officer07/31/20196,851
Morrison BriggsChief Executive Officer02/04/2020100,000
Morrison BriggsChief Executive Officer10/10/201959,400
Morrison BriggsChief Executive Officer05/09/201999,726
Morrison BriggsChief Executive Officer05/13/201952,517
Meyers Michael L.SVP, Chief Medical Officer03/21/201939
Meyers Michael L.SVP, Chief Medical Officer03/21/20195,436
Shea Richard PChief Financial Officer01/31/201912,000
Meyers Michael L.SVP, Chief Medical Officer01/31/201917,707
Metzger Michael APresident and COO01/31/201912,657
Meyers Michael L.SVP, Chief Medical Officer10/30/2018958
Ordentlich PeterChief Scientific Officer04/03/201823,100
Ordentlich PeterChief Scientific Officer04/03/2018112,500
Ordentlich PeterChief Scientific Officer05/17/20172,255
Ordentlich PeterChief Scientific Officer05/17/201775,000
ROYSTON IVORDirector03/20/20171,718,750
ROYSTON IVORDirector03/08/20161,800,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2022
12/31/2021
9.99%
1Q
03/31/2022
06/30/2021
14.41%
3Q
03/31/2022
03/31/2021
14.52%
4Q
03/31/2022
12/31/2020
42.78%
5Q
Load More

Period of Report: 03/31/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2021
9.99%
1Q
06/30/2021
14.41%
3Q
03/31/2021
14.52%
4Q
12/31/2020
42.78%
5Q
Load More